• HOME
  • FAQs
  • NEWS
  • FULL PRESCRIBING INFORMATION
  • About VETMEDIN
    • Dual-acting inodilator
    • VETMEDIN
      in CHF
    |
  • About CHF|
    • Signs of CHF
    • AVVI
    • DCM
    • Diagnosing CHF
  • Act Now—Use VETMEDIN|
    • CHF treatment
    • Importance of acting now
    • 2009 ACVIM consensus statement
  • VETMEDIN Efficacy|
    • VetSCOPE
    • QUEST
  • Safety and Dosing|
    • Record of safe use
    • Dosage
  • VETMEDIN Programs
  • Signs of CHF
  • AVVI
  • DCM
  • Diagnosing CHF

USEFUL LINKS

  • VETMEDIN Full Prescribing
    Information
  • Cardiac Education Group
  • YourDogsHeart.com
  • Boehringer Ingelheim Vetmedica, Inc.
  • American College of Veterinary
    Internal Medicine

Atrioventricular valvular insufficiency (AVVI)

Overview

AVVI is a degenerative disease that damages heart valve leaflets as it progresses. This damage prevents heart valves from closing properly, allowing blood to leak backward into the atrium. This leakage eventually results in a heart murmur detectable via auscultation. Valve leakage impairs cardiac function and circulation, ultimately leading to congestive heart failure (CHF).

AVVI in action

Progression of AVVI

AVVI, the most frequent cause of CHF in dogs, is a slowly progressing disease.1,2 The prevalence of this disease gradually increases with age. AVVI affects3:

  • 10% of dogs 5 to 8 years of age
  • 20% to 25% of dogs 9 to 12 years of age
  • 30% to 35% of dogs over age 13 years

This increase is especially dramatic in small breeds, with up to 85% showing evidence of valvular lesions at necropsy by 13 years of age.4

Breeds at risk for AVVI

AVVI occurs most often in small- to medium-sized breeds of dogs.1 Breeds most susceptible to AVVI include the Boston Terrier, Cavalier King Charles Spaniel, Chihuahua, Miniature Pinscher, Miniature and Toy Poodle, Pekingese, and Pomeranian.5 Ultimately, all small breed dogs are at risk for CHF due to AVVI.

References:

1. Rush JE. Chronic valvular heart disease in dogs. Proceedings from the 26th Annual Waltham Diets/OSU Symposium for the Treatment of Small Animal Cardiology; October 19–20, 2002. Available at: www.vin.com/proceedings/Proceedings.plx?CID=WALTHAMOSU2002&PID=2988. Accessed January 21, 2011. 2. Sisson D. Valvular heart disease in dogs. Proceedings from the WSAVA 2002 Congress; October 3–6, 2002; Granada, Spain. Available at: www.vin.com/proceedings/Proceedings.plx?CID=WSAVA2002&PID=2532. Accessed January 21, 2011. 3. Lombard CW, Jöns O, Bussadori CM; for the VetSCOPE Study. Clinical efficacy of pimobendan versus benazepril for the treatment of acquired atrioventricular valvular disease in dogs. J Am Anim Hosp Assoc. 2006;42(4):249–261. 4. Atkins C, Bonagura J, Ettinger S, et al. Guidelines for the diagnosis and treatment of canine chronic valvular heart disease. J Vet Intern Med. 2009;23(6):1142–1150. 5. Ware WA. Cardiovascular Disease in Small Animal Medicine. Ames, IA: Blackwell Publishing Professional; 2007.

Important safety information

VETMEDIN should not be given in case of hypertrophic cardiomyopathy, aortic stenosis, or any other clinical condition where an augmentation of cardiac output is inappropriate for functional or anatomical reasons. The safety of VETMEDIN has not been established in dogs with asymptomatic heart disease or in heart failure caused by etiologies other than atrioventricularvalvular insufficiency or dilated cardiomyopathy. The safe use of VETMEDIN has not been evaluated in dogs younger than 6 months of age, dogs with congenital heart defects, dogs with diabetes mellitus or other serious metabolic diseases, dogs used for breeding, or pregnant or lactating bitches. Use only in dogs with clinical evidence of heart failure. The most common side effects reported in field studies were poor appetite, lethargy, diarrhea, dyspnea, azotemia, weakness, and ataxia. If side effects should occur, pet owners should contact their veterinarian. Please refer to the Full Prescribing Information here.

Home Site Map Terms of Use Privacy Contact About Boehringer Ingelheim Vetmedica,Inc.
VETMEDIN is a registered trademark of Boehringer Ingelheim Vetmedica GmbH, licensed to Boehringer Ingelheim Vetmedica, Inc.
© 2015 Boehringer Ingelheim Vetmedica, Inc.